Filing Details

Accession Number:
0001104659-13-006700
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2013-02-01 10:06:38
Reporting Period:
2013-01-30
Filing Date:
2013-02-01
Accepted Time:
2013-02-01 10:06:38
Original Submission Date:
2013-01-30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1347613 Synergy Pharmaceuticals Inc. SGYP Pharmaceutical Preparations (2834) 330505269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253803 Gabriel Cerrone C/O Synergy Pharmaceuticals Inc.
420 Lexington Avenue, Suite 1609
New York NY 10170
Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-30 6,000 $5.97 842,783 No 4 P Indirect By Panetta Partners, Ltd.
Common Stock Acquisiton 2013-01-30 20,000 $5.99 862,783 No 4 P Indirect By Panetta Partners, Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Panetta Partners, Ltd.
No 4 P Indirect By Panetta Partners, Ltd.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 187,470 Direct
Footnotes
  1. Mr. Cerrone is the sole director of Panetta Partners Ltd. and in such capacity exercise voting and dispositive control over securities owned by Panetta Partners Ltd. despite him having only a small pecuniary interest in such securities.